Rezultati - Patricia Marinello

Refine Results
  1. 1
    A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial

    A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial od Gabriela Gonzalez, Tania Crombet, Mauricio Catalá, V. Mirabal, Juan C. Hernández, Yanela Santiesteban González, Patricia Marinello, Gerardo Guillén, A. Lage

    Izdano 1998
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failure

    KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failure od Philippe Armand, John Kuruvilla, Jean‐Marie Michot, Vincent Ribrag, Pier Luigi Zinzani, Ying Zhu, Patricia Marinello, Akash Nahar, Craig H. Moskowitz

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Anti-PD1 associated fulminant myocarditis after a single pembrolizumab dose: the role of occult pre-existing autoimmunity

    Anti-PD1 associated fulminant myocarditis after a single pembrolizumab dose: the role of occult pre-existing autoimmunity od Nicolás Martínez‐Calle, Paula Rodríguez‐Otero, Sara Villar, Luis D. Mejías, Ignacio Melero, Felipe Prósper, Patricia Marinello, Bruno Paiva, Miguel Á. Idoate, Jesús F. San Miguel

    Izdano 2018
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Phase 1b trial of pembrolizumab monotherapy for relapsed/refractory multiple myeloma: <scp>KEYNOTE</scp>‐013

    Phase 1b trial of pembrolizumab monotherapy for relapsed/refractory multiple myeloma: <scp>KEYNOTE</scp>‐013 od Vincent Ribrag, David Avigan, Damian J. Green, Trisha M. Wise‐Draper, Juan G. Posada, Ravi Vij, Ying Zhu, Mohammed Z.H. Farooqui, Patricia Marinello, David S. Siegel

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: Report from a phase I/II trial

    Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: Report from a phase I/II trial od Tania Crombet, Javier Figueredo, Mauricio Catalá, G. Sandra, Julio César Selva, T. Cruz, Carolina Toledo, Sérgio Silva, Yanet Pestano, Mayra Ramos, I. Leonard, Olga Torres, Patricia Marinello, Rolando Pérez, Agustín Lage

    Izdano 2006
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Pembrolizumab combined with lenalidomide and low‐dose dexamethasone for relapsed or refractory multiple myeloma: phase I <scp>KEYNOTE</scp>‐023 study

    Pembrolizumab combined with lenalidomide and low‐dose dexamethasone for relapsed or refractory multiple myeloma: phase I <scp>KEYNOTE</scp>‐023 study od María‐Victoria Mateos, Robert Z. Orlowski, Enrique M. Ocio, Paula Rodríguez‐Otero, Donna Reece, Philippe Moreau, Nikhil C. Munshi, David Avigan, David S. Siegel, Razi Ghori, Mohammed Farooqui, Patricia Marinello, Jesús F. San Miguel

    Izdano 2019
    Polni tekst Polni tekst
    Carta
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Pembrolizumab in Combination with Lenalidomide and Low-Dose Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM): Keynote-023

    Pembrolizumab in Combination with Lenalidomide and Low-Dose Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM): Keynote-023 od Jesús F. San Miguel, María‐Victoria Mateos, Jatin J. Shah, Enrique M. Ocio, Paula Rodríguez‐Otero, Donna Reece, Nikhil C. Munshi, David Avigan, Yang Ge, Arun Balakumaran, Patricia Marinello, Robert Z. Orlowski, David S. Siegel

    Izdano 2015
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Pembrolizumab in relapsed or refractory Richter syndrome

    Pembrolizumab in relapsed or refractory Richter syndrome od Philippe Armand, Niels Murawski, Daniel Molin, Jasmine Zain, Barbara Eichhorst, Zafer Gülbaş, Eliza A. Hawkes, John M. Pagel, Tycel Phillips, Vincent Ribrag, Jakub Svoboda, Anastasios Stathis, Arkendu Chatterjee, Robert Orlowski, Patricia Marinello, Beth Christian

    Izdano 2020
    Polni tekst
    Carta
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Final Analysis of Keynote-170: Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL)

    Final Analysis of Keynote-170: Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL) od Pier Luigi Zinzani, Catherine Thiéblemont, В Я Мельниченко, Krimo Bouabdallah, Jan Waleswski, Alejandro Majlis, Laura Fogliatto, Alejandro Martı́n, Beth Christian, Zafer Gülbaş, Muhi̇t Özcan, Guilherme Fleury Perini, Gilles Salles, Margaret A. Shipp, Seth Thompson, Samhita Chakraborty, Patricia Marinello, Philippe Armand

    Izdano 2021
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma: Final Analysis of KEYNOTE-170

    Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma: Final Analysis of KEYNOTE-170 od Pier Luigi Zinzani, Catherine Thiéblemont, В Я Мельниченко, Krimo Bouabdallah, Jan Walewski, Alejandro Majlis, Laura Fogliatto, Alejandro Martı́n, Beth Christian, Zafer Gülbaş, Muhi̇t Özcan, Guilherme Fleury Perini, Hervé Ghesquières, Margaret A. Shipp, Seth Thompson, Samhita Chakraborty, Patricia Marinello, Philippe Armand

    Izdano 2023
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Pembrolizumab in relapsed or refractory Hodgkin lymphoma: a post hoc analysis of KEYNOTE-204 by prior lines of therapy

    Pembrolizumab in relapsed or refractory Hodgkin lymphoma: a post hoc analysis of KEYNOTE-204 by prior lines of therapy od John Kuruvilla, Dipenkumar Modi, Armando Santoro, Ewa Paszkiewicz‐Kozik, Robin Gasiorowski, Nathalie A. Johnson, Laura Fogliatto, Iara Gonçalves, José de Lima Oliveira, Valéria Buccheri, Guilherme Fleury Perini, Neta Goldschmidt, Iryna Kriachok, Naohiro Sekiguchi, Jianxin Lin, Rushdia Z. Yusuf, Patricia Marinello, Pier Luigi Zinzani

    Izdano 2025
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Pembrolizumab in microsatellite instability high cancers: Updated analysis of the phase II KEYNOTE-164 and KEYNOTE-158 studies

    Pembrolizumab in microsatellite instability high cancers: Updated analysis of the phase II KEYNOTE-164 and KEYNOTE-158 studies od Luis A. Díaz, Dung T. Le, Michele Maio, Paolo A. Ascierto, Ravit Geva, Daniel Motola‐Kuba, Thierry André, Eric Van Cutsem, Maya Gottfried, Elena Élez, J.P. Delord, Dirk Jäger, T.W. Kim, Rosine Guimbaud, Takayuki Yoshino, M. Chen, Kevin Norwood, Patricia Marinello, Aurélien Marabelle

    Izdano 2019
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    886MO Health-related quality of life (HRQoL) from KEYNOTE-204: A phase III, randomized, open-label study of pembrolizumab (pembro) vs brentuximab vedotin (BV) in relapsed or refractory classical Hodgkin lymphoma (R/R cHL)

    886MO Health-related quality of life (HRQoL) from KEYNOTE-204: A phase III, randomized, open-label study of pembrolizumab (pembro) vs brentuximab vedotin (BV) in relapsed or refrac... od Pier Luigi Zinzani, Rod Ramchandren, Armando Santoro, Ewa Paszkiewicz‐Kozik, Robin Gasiorowski, Nathalie A. Johnson, José Salvador Rodrigues de Oliveira, Valéria Buccheri, Guilherme Fleury Perini, Michael Dickinson, Andrew McDonald, Muhi̇t Özcan, Naohiro Sekiguchi, Monika Raut, Ying Zhu, Akash Nahar, Patricia Marinello, John Kuruvilla

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma

    Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma od Philippe Armand, Pier Luigi Zinzani, Hun Ju Lee, Nathalie A. Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P. Vassilakopoulos, Akihiro Tomita, Bastian von Tresckow, Margaret A. Shipp, Alex F. Herrera, Jianxin Lin, Eunhee Kim, Samhita Chakraborty, Patricia Marinello, Craig H. Moskowitz

    Izdano 2023
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Keynote-B68: Updated Efficacy and Safety of Pembrolizumab Every Six Weeks in Relapsed/Refractory Classical Hodgkin Lymphoma or Primary Mediastinal B-Cell Lymphoma

    Keynote-B68: Updated Efficacy and Safety of Pembrolizumab Every Six Weeks in Relapsed/Refractory Classical Hodgkin Lymphoma or Primary Mediastinal B-Cell Lymphoma od Andrew McDonald, Estelle Verburgh, Manuel Gotti, Antonio Pinto, Jan Maciej Zaucha, Vladimir Ivanov, В Я Мельниченко, Heidi Móciková, Muhi̇t Özcan, Caterina Patti, João Farias, Iara Gonçalves, Olha Kuchkova, Jiřı́ Mayer, Güray Saydam, Sarah Tomassetti, Kumudu Pathiraja, Katherine Elizabeth Ryland, Patricia Marinello, Wojciech Jurczak

    Izdano 2023
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study

    Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-... od Luis A. Díaz, Kai‐Keen Shiu, Tae‐Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, Cornelis J.A. Punt, Denis Smith, Rocio García‐Carbonero, Manuel Benavides, Peter Gibbs, Christelle de la Fourchardière, Fernando Rivera, Elena Élez, Dung T. Le, Takayuki Yoshino, Wen Yan Zhong, David R. Fogelman, Patricia Marinello, Thierry André

    Izdano 2022
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164

    Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164 od Dung T. Le, Tae Won Kim, Eric Van Cutsem, Ravit Geva, Dirk Jäger, Hiroki Hara, Matthew Burge, Bert H. O’Neil, Petr Kavan, Takayuki Yoshino, Rosine Guimbaud, Hiroya Taniguchi, Elena Élez, Salah‐Eddin Al‐Batran, Patrick M. Boland, Todd S. Crocenzi, Chloé E. Atreya, Yi Cui, Tong Dai, Patricia Marinello, Luis A. Díaz, Thierry André

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Pembrolizumab (pembro) in Children and Young Adults with Low-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Early Results from the Phase 2 Keynote-667 Study

    Pembrolizumab (pembro) in Children and Young Adults with Low-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Early Results... od Lisa Roth, Frank G. Keller, Mario Melgar Toledo, Sharon M. Castellino, Christopher J. Forlenza, Maitane Andión Catalán, Julie Krystal, Adam J. Lamble, Aarati V. Rao, Fabio Molina Morales, Stacy Cooper, Flávio Augusto Vercillo Luisi, Óscar González Llano, Karla Alejandra Lopez, Christine Mauz-Koerholz, Bradford S. Hoppe, Juan Shen, Pallavi Pillai, Patricia Marinello, Kara M. Kelly

    Izdano 2023
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

    Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer od Thierry André, Kai‐Keen Shiu, Tae Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, Cornelis J.A. Punt, Denis Smith, Rocio García‐Carbonero, Manuel Benavides, Peter Gibbs, Christelle de la Fouchardière, Fernando Rivera, Elena Élez, Johanna C. Bendell, Dung T. Le, Takayuki Yoshino, Eric Van Cutsem, Ping Yang, Mohammed Z.H. Farooqui, Patricia Marinello, Luis A. Díaz

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

    Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial od Saad Z. Usmani, Fredrik Schjesvold, Albert Oriol, Lionel Karlin, Michèle Cavo, Robert M. Rifkin, Habte A. Yimer, Richard LeBlanc, Naoki Takezako, Robert McCroskey, Andrew Lim, Kenshi Suzuki, Hiroshi Kosugi, George Grigoriadis, Irit Avivi, Thierry Façon, Sundar Jagannath, Sagar Lonial, Razi Ghori, Mohammed Z.H. Farooqui, Patricia Marinello, Jesús F. San Miguel, Andrew Lim, George Grigoriadis, Trish Walker, Andrew J. Nicol, Richard LeBlanc, Donna Reece, Mohamed Elemary, Jean Samuel Boudreault Pedneault, Lionel Karlin, Thierry Façon, Michel Attal, Katja Weisel, Monika Engelhardt, Andréas Mackensen, John Quinn, Irit Avivi, Amos Cohen, Hila Magen‐Nativ, Noam Benyamini, Michèle Cavo, Alessandra Larocca, Naoki Takezako, Kenshi Suzuki, Hiroshi Kosugi, Morio Matsumoto, Shinsuke Iida, Takayuki Ishikawa, Yukio Kondo, Kazutaka Sunami, Kiyoshi Ando, Takanori Teshima, Takaaki Chou, Hiromi Iwasaki, Hirokazu Miki, Itaru Matsumura, Yasushi Onishi, Koji Izutsu, Masahiro Kizaki, Anupkumar George, Hillary Blacklock, David Simpson, Fredrik Schjesvold, Anders Waage, Olga Samoilova, Evgeniy Nikitin, Tatiana Chagorova, Andrew M. McDonald, Moosa Patel, Albert Oriol, Jesus San Miguel Izquierdo, María‐Victoria Mateos, Matthew Streetly, Peter Forsyth, Graham Jackson, Stephen J. Jenkins, Robert M. Rifkin, Habte A. Yimer, Robert McCroskey, Danko Martincic, Stefano Tarantolo, Sarah Larson, Yacoub Faroun, Jennifer Vaughn, Rachid Baz, Gene Saylors, Amarendra Neppalli, Anastasios Raptis, Henry C. Fung, Maxwell Janosky, Don A. Stevens, Morton Coleman, Dennis Costa, Scott Cross, Suzanne Fanning, Daniel Farray Berges, Thomas M. Harris, Ira Zackon, Djordje Atanackovic

    Izdano 2019
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: